Novel motif:79: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
(2 intermediate revisions by the same user not shown) | |||
Line 1: | Line 1: | ||
{ |
Latest revision as of 14:56, 9 September 2013
name: | motif79_ACATCTACAA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0050896 | response to stimulus | 1.068932e-17 |
GO:0014866 | skeletal myofibril assembly | 4.843161e-17 |
GO:0048747 | muscle fiber development | 1.714987e-16 |
GO:0048856 | anatomical structure development | 2.665631e-16 |
GO:0010038 | response to metal ion | 2.960143e-16 |
GO:0055002 | striated muscle cell development | 4.830660e-16 |
GO:0030261 | chromosome condensation | 6.538789e-16 |
GO:0055001 | muscle cell development | 7.884028e-16 |
GO:0032502 | developmental process | 1.297763e-15 |
GO:0030241 | skeletal muscle myosin thick filament assembly | 2.467896e-15 |
GO:0031032 | actomyosin structure organization | 2.548240e-15 |
GO:0051592 | response to calcium ion | 3.631857e-15 |
GO:0010035 | response to inorganic substance | 5.083206e-15 |
GO:0032501 | multicellular organismal process | 1.708367e-14 |
GO:0030239 | myofibril assembly | 2.041734e-14 |
GO:0051641 | cellular localization | 2.964637e-14 |
GO:0072358 | cardiovascular system development | 6.936258e-14 |
GO:0002576 | platelet degranulation | 7.200670e-14 |
GO:0051234 | establishment of localization | 7.738135e-14 |
GO:0034621 | cellular macromolecular complex subunit organization | 1.057453e-13 |
GO:0048739 | cardiac muscle fiber development | 1.379095e-13 |
GO:0048646 | anatomical structure formation involved in morphogenesis | 1.666846e-13 |
GO:0009888 | tissue development | 1.723754e-13 |
GO:0009653 | anatomical structure morphogenesis | 1.819948e-13 |
GO:0002694 | regulation of leukocyte activation | 2.329990e-13 |
GO:0018149 | peptide cross-linking | 3.116179e-13 |
GO:0006323 | DNA packaging | 4.764179e-13 |
GO:0006928 | cellular component movement | 8.801718e-13 |
GO:0051649 | establishment of localization in cell | 1.015141e-12 |
GO:0007275 | multicellular organismal development | 1.023434e-12 |
GO:0030240 | skeletal muscle thin filament assembly | 1.491601e-12 |
GO:0051179 | localization | 1.601125e-12 |
GO:0006996 | organelle organization | 1.827331e-12 |
GO:0050865 | regulation of cell activation | 2.969141e-12 |
GO:0006810 | transport | 3.170049e-12 |
GO:0042060 | wound healing | 3.576186e-12 |
GO:0030168 | platelet activation | 3.930830e-12 |
GO:0034622 | cellular macromolecular complex assembly | 4.100082e-12 |
GO:0032764 | negative regulation of mast cell cytokine production | 5.312722e-12 |
GO:0042692 | muscle cell differentiation | 8.535503e-12 |
GO:0048731 | system development | 1.025693e-11 |
GO:0030299 | intestinal cholesterol absorption | 1.132302e-11 |
GO:0001775 | cell activation | 1.231241e-11 |
GO:0043623 | cellular protein complex assembly | 1.400866e-11 |
GO:0022600 | digestive system process | 1.605261e-11 |
GO:0048513 | organ development | 1.698658e-11 |
GO:0071103 | DNA conformation change | 2.045950e-11 |
GO:0007076 | mitotic chromosome condensation | 2.312205e-11 |
GO:0050794 | regulation of cellular process | 3.341002e-11 |
GO:0071844 | cellular component assembly at cellular level | 3.863521e-11 |
GO:0030029 | actin filament-based process | 4.144456e-11 |
GO:0032940 | secretion by cell | 4.213840e-11 |
GO:0051146 | striated muscle cell differentiation | 4.356343e-11 |
GO:0001101 | response to acid | 4.680650e-11 |
GO:0065008 | regulation of biological quality | 4.872402e-11 |
GO:0002376 | immune system process | 5.045312e-11 |
GO:0061061 | muscle structure development | 5.325728e-11 |
GO:0071842 | cellular component organization at cellular level | 7.000223e-11 |
GO:0030048 | actin filament-based movement | 7.612150e-11 |
GO:0046903 | secretion | 7.750301e-11 |
GO:0050892 | intestinal absorption | 9.453952e-11 |
GO:0070252 | actin-mediated cell contraction | 9.589901e-11 |
GO:0010927 | cellular component assembly involved in morphogenesis | 1.012868e-10 |
GO:0009611 | response to wounding | 1.031175e-10 |
GO:0003008 | system process | 1.093592e-10 |
GO:0002682 | regulation of immune system process | 1.300713e-10 |
GO:0007586 | digestion | 1.379713e-10 |
GO:0065007 | biological regulation | 1.573227e-10 |
GO:0006788 | heme oxidation | 2.341776e-10 |
GO:0071363 | cellular response to growth factor stimulus | 2.643287e-10 |
GO:0006940 | regulation of smooth muscle contraction | 2.972227e-10 |
GO:0045214 | sarcomere organization | 3.259448e-10 |
GO:0030049 | muscle filament sliding | 4.009494e-10 |
GO:0050789 | regulation of biological process | 4.051155e-10 |
GO:0071841 | cellular component organization or biogenesis at cellular level | 4.256155e-10 |
GO:0048769 | sarcomerogenesis | 6.076204e-10 |
GO:0010838 | positive regulation of keratinocyte proliferation | 6.319870e-10 |
GO:0061033 | secretion by lung epithelial cell involved in lung growth | 6.319870e-10 |
GO:0030036 | actin cytoskeleton organization | 6.435128e-10 |
GO:0071230 | cellular response to amino acid stimulus | 8.976172e-10 |
GO:0055003 | cardiac myofibril assembly | 9.226216e-10 |
GO:0014806 | smooth muscle hyperplasia | 1.133818e-9 |
GO:0050867 | positive regulation of cell activation | 1.354800e-9 |
GO:0071229 | cellular response to acid | 1.434663e-9 |
GO:0031295 | T cell costimulation | 1.860101e-9 |
GO:0002696 | positive regulation of leukocyte activation | 1.969521e-9 |
GO:0051249 | regulation of lymphocyte activation | 1.974129e-9 |
GO:0003012 | muscle system process | 2.315403e-9 |
GO:0043500 | muscle adaptation | 2.419035e-9 |
GO:0048584 | positive regulation of response to stimulus | 2.471892e-9 |
GO:0045766 | positive regulation of angiogenesis | 3.554228e-9 |
GO:0055013 | cardiac muscle cell development | 3.875920e-9 |
GO:0050776 | regulation of immune response | 4.691333e-9 |
GO:0050878 | regulation of body fluid levels | 7.374140e-9 |
GO:0071417 | cellular response to organic nitrogen | 8.133042e-9 |
GO:0071840 | cellular component organization or biogenesis | 9.033354e-9 |
GO:0007507 | heart development | 1.039529e-8 |
GO:0071418 | cellular response to amine stimulus | 1.069475e-8 |
GO:0000819 | sister chromatid segregation | 1.156787e-8 |
GO:0006950 | response to stress | 1.221952e-8 |
GO:0043200 | response to amino acid stimulus | 1.276830e-8 |
GO:0000070 | mitotic sister chromatid segregation | 1.287594e-8 |
GO:0032763 | regulation of mast cell cytokine production | 1.394711e-8 |
GO:0009605 | response to external stimulus | 1.897057e-8 |
GO:0007015 | actin filament organization | 1.914210e-8 |
GO:0051251 | positive regulation of lymphocyte activation | 3.331324e-8 |
GO:0032989 | cellular component morphogenesis | 3.415360e-8 |
GO:0048661 | positive regulation of smooth muscle cell proliferation | 4.114783e-8 |
GO:0010667 | negative regulation of cardiac muscle cell apoptosis | 4.294336e-8 |
GO:0048518 | positive regulation of biological process | 4.813429e-8 |
GO:0035051 | cardiac cell differentiation | 4.816724e-8 |
GO:0001568 | blood vessel development | 5.158805e-8 |
GO:0016043 | cellular component organization | 5.178376e-8 |
GO:0061088 | regulation of sequestering of zinc ion | 5.586398e-8 |
GO:0044241 | lipid digestion | 6.794853e-8 |
GO:0032103 | positive regulation of response to external stimulus | 6.876578e-8 |
GO:0050851 | antigen receptor-mediated signaling pathway | 7.023978e-8 |
GO:0007010 | cytoskeleton organization | 7.574910e-8 |
GO:0048583 | regulation of response to stimulus | 7.820219e-8 |
GO:0032964 | collagen biosynthetic process | 9.327432e-8 |
GO:0051272 | positive regulation of cellular component movement | 9.762714e-8 |
GO:0043551 | regulation of phosphatidylinositol 3-kinase activity | 9.797032e-8 |
GO:0002429 | immune response-activating cell surface receptor signaling pathway | 9.856337e-8 |
GO:0001944 | vasculature development | 1.034119e-7 |
GO:0002684 | positive regulation of immune system process | 1.086213e-7 |
GO:0002768 | immune response-regulating cell surface receptor signaling pathway | 1.242673e-7 |
GO:0005983 | starch catabolic process | 1.258631e-7 |
GO:0048468 | cell development | 1.265874e-7 |
GO:0007596 | blood coagulation | 1.326883e-7 |
GO:0007165 | signal transduction | 1.439244e-7 |
GO:0048738 | cardiac muscle tissue development | 1.442831e-7 |
GO:0030199 | collagen fibril organization | 1.471402e-7 |
GO:0043305 | negative regulation of mast cell degranulation | 1.487281e-7 |
GO:0007599 | hemostasis | 1.535832e-7 |
GO:0060537 | muscle tissue development | 1.622523e-7 |
GO:0051716 | cellular response to stimulus | 1.666811e-7 |
GO:0030335 | positive regulation of cell migration | 1.762764e-7 |
GO:0050864 | regulation of B cell activation | 1.791794e-7 |
GO:0031296 | B cell costimulation | 1.806782e-7 |
GO:0046660 | female sex differentiation | 1.815836e-7 |
GO:0040017 | positive regulation of locomotion | 1.902592e-7 |
GO:0030890 | positive regulation of B cell proliferation | 1.931230e-7 |
GO:0002548 | monocyte chemotaxis | 1.954016e-7 |
GO:0043503 | skeletal muscle fiber adaptation | 2.222006e-7 |
GO:0044036 | cell wall macromolecule metabolic process | 2.308870e-7 |
GO:0014706 | striated muscle tissue development | 2.324086e-7 |
GO:0045663 | positive regulation of myoblast differentiation | 2.360925e-7 |
GO:0030154 | cell differentiation | 2.511954e-7 |
GO:0040011 | locomotion | 2.526915e-7 |
GO:0048520 | positive regulation of behavior | 2.771654e-7 |
GO:2000147 | positive regulation of cell motility | 2.960542e-7 |
GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling | 2.976656e-7 |
GO:0042167 | heme catabolic process | 3.100066e-7 |
GO:0048869 | cellular developmental process | 3.940219e-7 |
GO:0045765 | regulation of angiogenesis | 4.034345e-7 |
GO:0070848 | response to growth factor stimulus | 4.106111e-7 |
GO:0043550 | regulation of lipid kinase activity | 4.335143e-7 |
GO:0002920 | regulation of humoral immune response | 4.366693e-7 |
GO:0055007 | cardiac muscle cell differentiation | 4.980259e-7 |
GO:0046545 | development of primary female sexual characteristics | 5.545450e-7 |
GO:0022607 | cellular component assembly | 5.584790e-7 |
GO:0071157 | negative regulation of cell cycle arrest | 5.725089e-7 |
GO:0033007 | negative regulation of mast cell activation involved in immune response | 6.016493e-7 |
GO:0060437 | lung growth | 6.095850e-7 |
GO:0010664 | negative regulation of striated muscle cell apoptosis | 6.783067e-7 |
GO:0006887 | exocytosis | 6.837846e-7 |
GO:0034394 | protein localization at cell surface | 7.011681e-7 |
GO:0046824 | positive regulation of nucleocytoplasmic transport | 7.013030e-7 |
GO:0032388 | positive regulation of intracellular transport | 7.044394e-7 |
GO:0006458 | 'de novo' protein folding | 7.160248e-7 |
GO:0016998 | cell wall macromolecule catabolic process | 7.335292e-7 |
GO:0006955 | immune response | 7.843287e-7 |
GO:0009306 | protein secretion | 9.007865e-7 |
GO:0044085 | cellular component biogenesis | 1.058549e-6 |
GO:0048870 | cell motility | 1.078366e-6 |
GO:0043552 | positive regulation of phosphatidylinositol 3-kinase activity | 1.084432e-6 |
GO:0006936 | muscle contraction | 1.176514e-6 |
GO:0032963 | collagen metabolic process | 1.199444e-6 |
GO:0014075 | response to amine stimulus | 1.217289e-6 |
GO:0090316 | positive regulation of intracellular protein transport | 1.342930e-6 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 1.441658e-6 |
GO:0030888 | regulation of B cell proliferation | 1.455236e-6 |
GO:0044259 | multicellular organismal macromolecule metabolic process | 1.468837e-6 |
GO:0007207 | activation of phospholipase C activity by muscarinic acetylcholine receptor signaling pathway | 1.513149e-6 |
GO:0044236 | multicellular organismal metabolic process | 1.541578e-6 |
GO:0009991 | response to extracellular stimulus | 1.548047e-6 |
GO:0061153 | trachea gland development | 1.603046e-6 |
GO:0071577 | zinc ion transmembrane transport | 1.775511e-6 |
GO:0051084 | 'de novo' posttranslational protein folding | 1.864257e-6 |
GO:0071294 | cellular response to zinc ion | 1.886058e-6 |
GO:0042221 | response to chemical stimulus | 1.909410e-6 |
GO:0002757 | immune response-activating signal transduction | 1.919437e-6 |
GO:0002885 | positive regulation of hypersensitivity | 1.963658e-6 |
GO:0050863 | regulation of T cell activation | 2.052668e-6 |
GO:0002764 | immune response-regulating signaling pathway | 2.232696e-6 |
GO:0001525 | angiogenesis | 2.374316e-6 |
GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress | 2.457060e-6 |
GO:0006644 | phospholipid metabolic process | 2.532981e-6 |
GO:0006434 | seryl-tRNA aminoacylation | 2.587653e-6 |
GO:0035924 | cellular response to vascular endothelial growth factor stimulus | 2.753799e-6 |
GO:0048263 | determination of dorsal identity | 2.768552e-6 |
GO:0022002 | negative regulation of anterior neural cell fate commitment of the neural plate by Wnt receptor signaling pathway | 2.768552e-6 |
GO:0006333 | chromatin assembly or disassembly | 2.788754e-6 |
GO:0048522 | positive regulation of cellular process | 2.917491e-6 |
GO:0060541 | respiratory system development | 3.148853e-6 |
GO:0006629 | lipid metabolic process | 3.156535e-6 |
GO:0007517 | muscle organ development | 3.208223e-6 |
GO:0007162 | negative regulation of cell adhesion | 3.283008e-6 |
GO:0031667 | response to nutrient levels | 3.510186e-6 |
GO:0014805 | smooth muscle adaptation | 3.514262e-6 |
GO:0001935 | endothelial cell proliferation | 3.534448e-6 |
GO:0002683 | negative regulation of immune system process | 3.599967e-6 |
GO:0055069 | zinc ion homeostasis | 3.769442e-6 |
GO:0006069 | ethanol oxidation | 3.839551e-6 |
GO:0002719 | negative regulation of cytokine production involved in immune response | 3.992276e-6 |
GO:0043392 | negative regulation of DNA binding | 4.195405e-6 |
GO:0051222 | positive regulation of protein transport | 4.221944e-6 |
GO:0006941 | striated muscle contraction | 4.286033e-6 |
GO:0065009 | regulation of molecular function | 4.373271e-6 |
GO:0051098 | regulation of binding | 4.699174e-6 |
GO:0050871 | positive regulation of B cell activation | 4.737261e-6 |
GO:0002820 | negative regulation of adaptive immune response | 5.031056e-6 |
GO:0010665 | regulation of cardiac muscle cell apoptosis | 5.040103e-6 |
GO:0051149 | positive regulation of muscle cell differentiation | 5.107708e-6 |
GO:0008610 | lipid biosynthetic process | 5.109664e-6 |
GO:0090218 | positive regulation of lipid kinase activity | 5.172103e-6 |
GO:0021881 | Wnt receptor signaling pathway involved in forebrain neuron fate commitment | 5.174451e-6 |
GO:0016192 | vesicle-mediated transport | 5.496976e-6 |
GO:0043549 | regulation of kinase activity | 6.039143e-6 |
GO:0031099 | regeneration | 6.092418e-6 |
GO:0048514 | blood vessel morphogenesis | 6.165900e-6 |
GO:0050777 | negative regulation of immune response | 6.499560e-6 |
GO:0007154 | cell communication | 6.547454e-6 |
GO:0048262 | determination of dorsal/ventral asymmetry | 6.636656e-6 |
GO:0033036 | macromolecule localization | 6.826568e-6 |
GO:0023052 | signaling | 7.217555e-6 |
GO:0045023 | G0 to G1 transition | 7.834508e-6 |
GO:0008284 | positive regulation of cell proliferation | 7.889669e-6 |
GO:0007166 | cell surface receptor linked signaling pathway | 8.167054e-6 |
GO:0000902 | cell morphogenesis | 8.288300e-6 |
GO:0007200 | activation of phospholipase C activity by G-protein coupled receptor protein signaling pathway coupled to IP3 second messenger | 8.914444e-6 |
GO:0060548 | negative regulation of cell death | 8.973273e-6 |
GO:0016477 | cell migration | 9.554751e-6 |
GO:0048872 | homeostasis of number of cells | 1.010873e-5 |
GO:0010243 | response to organic nitrogen | 1.017754e-5 |
GO:0010559 | regulation of glycoprotein biosynthetic process | 1.030278e-5 |
GO:0043933 | macromolecular complex subunit organization | 1.060900e-5 |
GO:0048762 | mesenchymal cell differentiation | 1.073566e-5 |
GO:0048878 | chemical homeostasis | 1.129185e-5 |
GO:0010656 | negative regulation of muscle cell apoptosis | 1.184287e-5 |
GO:0002883 | regulation of hypersensitivity | 1.258114e-5 |
GO:0065003 | macromolecular complex assembly | 1.377095e-5 |
GO:0051346 | negative regulation of hydrolase activity | 1.478004e-5 |
GO:0048016 | inositol phosphate-mediated signaling | 1.498786e-5 |
GO:0033004 | negative regulation of mast cell activation | 1.517739e-5 |
GO:0051276 | chromosome organization | 1.576646e-5 |
GO:0019637 | organophosphate metabolic process | 1.602568e-5 |
GO:0002634 | regulation of germinal center formation | 1.637829e-5 |
GO:0002866 | positive regulation of acute inflammatory response to antigenic stimulus | 1.664864e-5 |
GO:0051258 | protein polymerization | 1.672546e-5 |
GO:0034764 | positive regulation of transmembrane transport | 1.710699e-5 |
GO:0044255 | cellular lipid metabolic process | 1.767532e-5 |
GO:0008283 | cell proliferation | 1.786645e-5 |
GO:0007292 | female gamete generation | 1.906836e-5 |
GO:0035295 | tube development | 1.928081e-5 |
GO:0051094 | positive regulation of developmental process | 1.932478e-5 |
GO:0006959 | humoral immune response | 1.949103e-5 |
GO:0006349 | regulation of gene expression by genetic imprinting | 2.026031e-5 |
GO:0050793 | regulation of developmental process | 2.032513e-5 |
GO:0042307 | positive regulation of protein import into nucleus | 2.074796e-5 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 2.082768e-5 |
GO:0022603 | regulation of anatomical structure morphogenesis | 2.119463e-5 |
GO:0051024 | positive regulation of immunoglobulin secretion | 2.124223e-5 |
GO:0002697 | regulation of immune effector process | 2.156395e-5 |
GO:0051338 | regulation of transferase activity | 2.163945e-5 |
GO:0060693 | regulation of branching involved in salivary gland morphogenesis | 2.167611e-5 |
GO:0050900 | leukocyte migration | 2.201357e-5 |
GO:0050870 | positive regulation of T cell activation | 2.319057e-5 |
GO:2000679 | positive regulation of transcription regulatory region DNA binding | 2.424505e-5 |
GO:0007213 | muscarinic acetylcholine receptor signaling pathway | 2.448625e-5 |
GO:0009615 | response to virus | 2.697043e-5 |
GO:0006650 | glycerophospholipid metabolic process | 2.705128e-5 |
GO:0007059 | chromosome segregation | 2.746557e-5 |
GO:0048285 | organelle fission | 2.843046e-5 |
GO:0030540 | female genitalia development | 2.889417e-5 |
GO:0010662 | regulation of striated muscle cell apoptosis | 2.988601e-5 |
GO:0014068 | positive regulation of phosphatidylinositol 3-kinase cascade | 3.070671e-5 |
GO:0001817 | regulation of cytokine production | 3.136742e-5 |
GO:0019538 | protein metabolic process | 3.256450e-5 |
GO:0046854 | phosphatidylinositol phosphorylation | 3.279110e-5 |
GO:0060059 | embryonic retina morphogenesis in camera-type eye | 3.308060e-5 |
GO:0061039 | ovum-producing ovary development | 3.353877e-5 |
GO:0007067 | mitosis | 3.368108e-5 |
GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway | 3.406332e-5 |
GO:0014033 | neural crest cell differentiation | 3.536846e-5 |
GO:0097022 | lymphocyte migration into lymph node | 3.663448e-5 |
GO:0030301 | cholesterol transport | 3.771667e-5 |
GO:0001776 | leukocyte homeostasis | 3.774383e-5 |
GO:0014031 | mesenchymal cell development | 3.916514e-5 |
GO:0050790 | regulation of catalytic activity | 3.962241e-5 |
GO:0008104 | protein localization | 4.001117e-5 |
GO:0071514 | genetic imprinting | 4.144802e-5 |
GO:0043069 | negative regulation of programmed cell death | 4.171652e-5 |
GO:0002577 | regulation of antigen processing and presentation | 4.398641e-5 |
GO:0032848 | negative regulation of cellular pH reduction | 4.414564e-5 |
GO:0043375 | CD8-positive, alpha-beta T cell lineage commitment | 4.414564e-5 |
GO:0021747 | cochlear nucleus development | 4.414564e-5 |
GO:0014042 | positive regulation of neuron maturation | 4.414564e-5 |
GO:0034613 | cellular protein localization | 4.473911e-5 |
GO:0034720 | histone H3-K4 demethylation | 4.489520e-5 |
GO:0072610 | interleukin-12 secretion | 4.603528e-5 |
GO:0000114 | regulation of transcription involved in G1 phase of mitotic cell cycle | 4.603528e-5 |
GO:0002408 | myeloid dendritic cell chemotaxis | 4.603528e-5 |
GO:0000087 | M phase of mitotic cell cycle | 4.708019e-5 |
GO:0043129 | surfactant homeostasis | 4.793324e-5 |
GO:0002260 | lymphocyte homeostasis | 4.852117e-5 |
GO:0033561 | regulation of water loss via skin | 4.861356e-5 |
GO:2000107 | negative regulation of leukocyte apoptosis | 4.920543e-5 |
GO:0006937 | regulation of muscle contraction | 4.972543e-5 |
GO:0060897 | neural plate regionalization | 5.009603e-5 |
GO:0008206 | bile acid metabolic process | 5.129488e-5 |
GO:0034154 | toll-like receptor 7 signaling pathway | 5.214218e-5 |
GO:0031444 | slow-twitch skeletal muscle fiber contraction | 5.242345e-5 |
GO:0070727 | cellular macromolecule localization | 5.276947e-5 |
GO:0009887 | organ morphogenesis | 5.312807e-5 |
GO:0008654 | phospholipid biosynthetic process | 5.340334e-5 |
GO:0051239 | regulation of multicellular organismal process | 5.442332e-5 |
GO:0042592 | homeostatic process | 5.500841e-5 |
GO:0030449 | regulation of complement activation | 5.516641e-5 |
GO:0050921 | positive regulation of chemotaxis | 5.526737e-5 |
GO:0070271 | protein complex biogenesis | 5.527125e-5 |
GO:0043066 | negative regulation of apoptosis | 5.583250e-5 |
GO:0010837 | regulation of keratinocyte proliferation | 5.584913e-5 |
GO:0002253 | activation of immune response | 5.704898e-5 |
GO:0050853 | B cell receptor signaling pathway | 5.772900e-5 |
GO:0045738 | negative regulation of DNA repair | 5.810586e-5 |
GO:0055080 | cation homeostasis | 5.859533e-5 |
GO:0022602 | ovulation cycle process | 5.909441e-5 |
GO:0010810 | regulation of cell-substrate adhesion | 6.000558e-5 |
GO:0003007 | heart morphogenesis | 6.011796e-5 |
GO:0002703 | regulation of leukocyte mediated immunity | 6.188550e-5 |
GO:0030155 | regulation of cell adhesion | 6.240877e-5 |
GO:0048729 | tissue morphogenesis | 6.295556e-5 |
GO:2000008 | regulation of protein localization at cell surface | 6.543122e-5 |
GO:0060638 | mesenchymal-epithelial cell signaling | 6.569709e-5 |
GO:0051187 | cofactor catabolic process | 6.596439e-5 |
GO:0031497 | chromatin assembly | 6.715208e-5 |
GO:0002040 | sprouting angiogenesis | 6.787246e-5 |
GO:0006952 | defense response | 7.121238e-5 |
GO:0003219 | cardiac right ventricle formation | 7.483791e-5 |
GO:0050801 | ion homeostasis | 7.523955e-5 |
GO:0050707 | regulation of cytokine secretion | 7.558646e-5 |
GO:0006829 | zinc ion transport | 7.581758e-5 |
GO:0043501 | skeletal muscle adaptation | 7.594219e-5 |
GO:0051640 | organelle localization | 7.594332e-5 |
GO:0015918 | sterol transport | 7.606741e-5 |
GO:0010466 | negative regulation of peptidase activity | 7.623946e-5 |
GO:0006461 | protein complex assembly | 7.664605e-5 |
GO:0030324 | lung development | 7.706261e-5 |
GO:0043017 | positive regulation of lymphotoxin A biosynthetic process | 7.742104e-5 |
GO:0009893 | positive regulation of metabolic process | 7.782061e-5 |
GO:0002886 | regulation of myeloid leukocyte mediated immunity | 7.796258e-5 |
GO:0007005 | mitochondrion organization | 7.834377e-5 |
GO:0060485 | mesenchyme development | 7.894350e-5 |
GO:0002695 | negative regulation of leukocyte activation | 7.917765e-5 |
GO:0045859 | regulation of protein kinase activity | 8.059235e-5 |
GO:0001782 | B cell homeostasis | 8.090763e-5 |
GO:0034762 | regulation of transmembrane transport | 8.115778e-5 |
GO:0042596 | fear response | 8.165291e-5 |
GO:0051100 | negative regulation of binding | 8.228365e-5 |
GO:0051101 | regulation of DNA binding | 8.324791e-5 |
GO:0043301 | negative regulation of leukocyte degranulation | 8.459213e-5 |
GO:0006808 | regulation of nitrogen utilization | 8.570968e-5 |
GO:0042100 | B cell proliferation | 8.585125e-5 |
GO:0021999 | neural plate anterior/posterior regionalization | 9.052262e-5 |
GO:0032714 | negative regulation of interleukin-5 production | 9.052262e-5 |
GO:0050795 | regulation of behavior | 9.104399e-5 |
GO:2000021 | regulation of ion homeostasis | 9.168712e-5 |
GO:0052312 | modulation of transcription in other organism involved in symbiotic interaction | 9.411726e-5 |
GO:0032185 | septin cytoskeleton organization | 9.466949e-5 |
GO:0045869 | negative regulation of retroviral genome replication | 9.499423e-5 |
GO:0060662 | salivary gland cavitation | 9.602506e-5 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 9.650980e-5 |
GO:0051303 | establishment of chromosome localization | 9.675808e-5 |
GO:0048644 | muscle organ morphogenesis | 9.740993e-5 |
GO:0030091 | protein repair | 1.002170e-4 |
GO:0009584 | detection of visible light | 1.012502e-4 |
GO:0001654 | eye development | 1.014360e-4 |
GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly | 1.018652e-4 |
GO:0045073 | regulation of chemokine biosynthetic process | 1.023947e-4 |
GO:0002864 | regulation of acute inflammatory response to antigenic stimulus | 1.048113e-4 |
GO:0071822 | protein complex subunit organization | 1.051793e-4 |
GO:0045080 | positive regulation of chemokine biosynthetic process | 1.078199e-4 |
GO:0042698 | ovulation cycle | 1.102338e-4 |
GO:0032696 | negative regulation of interleukin-13 production | 1.123489e-4 |
GO:0002699 | positive regulation of immune effector process | 1.146319e-4 |
GO:0048010 | vascular endothelial growth factor receptor signaling pathway | 1.149044e-4 |
GO:0050891 | multicellular organismal water homeostasis | 1.162530e-4 |
GO:0030003 | cellular cation homeostasis | 1.175068e-4 |
GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway | 1.204369e-4 |
GO:0048742 | regulation of skeletal muscle fiber development | 1.224811e-4 |
GO:0010746 | regulation of plasma membrane long-chain fatty acid transport | 1.225498e-4 |
GO:0051656 | establishment of organelle localization | 1.235272e-4 |
GO:0071453 | cellular response to oxygen levels | 1.240478e-4 |
GO:0006325 | chromatin organization | 1.251244e-4 |
GO:0050778 | positive regulation of immune response | 1.268436e-4 |
GO:0021680 | cerebellar Purkinje cell layer development | 1.270564e-4 |
GO:0042157 | lipoprotein metabolic process | 1.275731e-4 |
GO:0051961 | negative regulation of nervous system development | 1.281824e-4 |
GO:0031669 | cellular response to nutrient levels | 1.296220e-4 |
GO:0048634 | regulation of muscle organ development | 1.328923e-4 |
GO:0002675 | positive regulation of acute inflammatory response | 1.332389e-4 |
GO:0009583 | detection of light stimulus | 1.354037e-4 |
GO:0034633 | retinol transport | 1.357787e-4 |
GO:0070613 | regulation of protein processing | 1.372977e-4 |
GO:0042127 | regulation of cell proliferation | 1.380124e-4 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.415311e-4 |
GO:0048592 | eye morphogenesis | 1.419808e-4 |
GO:0007584 | response to nutrient | 1.421837e-4 |
GO:0032642 | regulation of chemokine production | 1.438515e-4 |
GO:0008585 | female gonad development | 1.469521e-4 |
GO:0030323 | respiratory tube development | 1.473461e-4 |
GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep | 1.507182e-4 |
GO:0010043 | response to zinc ion | 1.511162e-4 |
GO:0090257 | regulation of muscle system process | 1.535191e-4 |
GO:0071276 | cellular response to cadmium ion | 1.535641e-4 |
GO:0030854 | positive regulation of granulocyte differentiation | 1.542790e-4 |
GO:0060415 | muscle tissue morphogenesis | 1.557416e-4 |
GO:0021678 | third ventricle development | 1.558026e-4 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.599081e-4 |
GO:0051549 | positive regulation of keratinocyte migration | 1.599081e-4 |
GO:0032990 | cell part morphogenesis | 1.602627e-4 |
GO:0034728 | nucleosome organization | 1.610497e-4 |
GO:0007186 | G-protein coupled receptor protein signaling pathway | 1.615861e-4 |
GO:0009855 | determination of bilateral symmetry | 1.668530e-4 |
GO:0008543 | fibroblast growth factor receptor signaling pathway | 1.682589e-4 |
GO:0043589 | skin morphogenesis | 1.693557e-4 |
GO:0001542 | ovulation from ovarian follicle | 1.733705e-4 |
GO:0006656 | phosphatidylcholine biosynthetic process | 1.736386e-4 |
GO:0002819 | regulation of adaptive immune response | 1.795170e-4 |
GO:0032847 | regulation of cellular pH reduction | 1.799039e-4 |
GO:0085029 | extracellular matrix assembly | 1.818151e-4 |
GO:0002698 | negative regulation of immune effector process | 1.856405e-4 |
GO:0040030 | regulation of molecular function, epigenetic | 1.867969e-4 |
GO:0045575 | basophil activation | 1.867969e-4 |
GO:0001694 | histamine biosynthetic process | 1.867969e-4 |
GO:0050670 | regulation of lymphocyte proliferation | 1.873270e-4 |
GO:0003266 | regulation of secondary heart field cardioblast proliferation | 1.885440e-4 |
GO:0019933 | cAMP-mediated signaling | 1.910827e-4 |
GO:0031060 | regulation of histone methylation | 1.917495e-4 |
GO:0032101 | regulation of response to external stimulus | 1.934679e-4 |
GO:0007399 | nervous system development | 1.938032e-4 |
GO:0042993 | positive regulation of transcription factor import into nucleus | 1.961573e-4 |
GO:0009987 | cellular process | 2.017989e-4 |
GO:0009799 | specification of symmetry | 2.019931e-4 |
GO:0044092 | negative regulation of molecular function | 2.030227e-4 |
GO:0050920 | regulation of chemotaxis | 2.032536e-4 |
GO:0014888 | striated muscle adaptation | 2.038834e-4 |
GO:0001503 | ossification | 2.081926e-4 |
GO:0048660 | regulation of smooth muscle cell proliferation | 2.087551e-4 |
GO:0048251 | elastic fiber assembly | 2.123650e-4 |
GO:0050663 | cytokine secretion | 2.128514e-4 |
GO:0043206 | fibril organization | 2.144739e-4 |
GO:0045909 | positive regulation of vasodilation | 2.249007e-4 |
GO:0048858 | cell projection morphogenesis | 2.261006e-4 |
GO:0003211 | cardiac ventricle formation | 2.262907e-4 |
GO:0046668 | regulation of retinal cell programmed cell death | 2.302161e-4 |
GO:0002823 | negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2.366409e-4 |
GO:0051336 | regulation of hydrolase activity | 2.408466e-4 |
GO:0035094 | response to nicotine | 2.441934e-4 |
GO:0061307 | cardiac neural crest cell differentiation involved in heart development | 2.499436e-4 |
GO:0022408 | negative regulation of cell-cell adhesion | 2.537535e-4 |
GO:0006911 | phagocytosis, engulfment | 2.544437e-4 |
GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis | 2.635921e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 2.647265e-4 |
GO:0009060 | aerobic respiration | 2.662762e-4 |
GO:0048741 | skeletal muscle fiber development | 2.683984e-4 |
GO:0000056 | ribosomal small subunit export from nucleus | 2.747683e-4 |
GO:0001957 | intramembranous ossification | 2.771693e-4 |
GO:0030279 | negative regulation of ossification | 2.784465e-4 |
GO:0010574 | regulation of vascular endothelial growth factor production | 2.823546e-4 |
GO:2000191 | regulation of fatty acid transport | 2.857311e-4 |
GO:0055008 | cardiac muscle tissue morphogenesis | 2.876231e-4 |
GO:0043030 | regulation of macrophage activation | 2.884463e-4 |
GO:0002604 | regulation of dendritic cell antigen processing and presentation | 2.916828e-4 |
GO:0035265 | organ growth | 3.094212e-4 |
GO:0030334 | regulation of cell migration | 3.178096e-4 |
GO:0010604 | positive regulation of macromolecule metabolic process | 3.178941e-4 |
GO:0051569 | regulation of histone H3-K4 methylation | 3.262317e-4 |
GO:0002673 | regulation of acute inflammatory response | 3.264046e-4 |
GO:0071173 | spindle assembly checkpoint | 3.276429e-4 |
GO:0032944 | regulation of mononuclear cell proliferation | 3.314429e-4 |
GO:0006873 | cellular ion homeostasis | 3.334416e-4 |
GO:0033689 | negative regulation of osteoblast proliferation | 3.413453e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 3.417210e-4 |
GO:0019079 | viral genome replication | 3.436185e-4 |
GO:0002921 | negative regulation of humoral immune response | 3.484509e-4 |
GO:0043461 | proton-transporting ATP synthase complex assembly | 3.524589e-4 |
GO:0021898 | commitment of multipotent stem cells to neuronal lineage in forebrain | 3.528784e-4 |
GO:0060343 | trabecula formation | 3.555024e-4 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0032849 | positive regulation of cellular pH reduction | 1.482120e-13 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.385015e-12 |
GO:0022417 | protein maturation by protein folding | 2.385015e-12 |
GO:0015670 | carbon dioxide transport | 3.374646e-12 |
GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan | 1.714133e-11 |
GO:0009268 | response to pH | 2.117889e-10 |
GO:0032847 | regulation of cellular pH reduction | 3.489943e-10 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 4.331429e-10 |
GO:0006022 | aminoglycan metabolic process | 2.891326e-9 |
GO:0048844 | artery morphogenesis | 8.056061e-9 |
GO:0032501 | multicellular organismal process | 8.586549e-9 |
GO:0030157 | pancreatic juice secretion | 1.003288e-8 |
GO:0045844 | positive regulation of striated muscle tissue development | 1.113738e-8 |
GO:0048743 | positive regulation of skeletal muscle fiber development | 1.338205e-8 |
GO:0010957 | negative regulation of vitamin D biosynthetic process | 2.597905e-8 |
GO:0007586 | digestion | 3.411696e-8 |
GO:0048643 | positive regulation of skeletal muscle tissue development | 4.211556e-8 |
GO:0034337 | RNA folding | 4.766216e-8 |
GO:0006707 | cholesterol catabolic process | 4.766216e-8 |
GO:0030203 | glycosaminoglycan metabolic process | 4.857900e-8 |
GO:0060840 | artery development | 5.276916e-8 |
GO:0050654 | chondroitin sulfate proteoglycan metabolic process | 1.005273e-7 |
GO:0007517 | muscle organ development | 1.050950e-7 |
GO:0035909 | aorta morphogenesis | 1.131977e-7 |
GO:0044029 | hypomethylation of CpG island | 1.260105e-7 |
GO:0030204 | chondroitin sulfate metabolic process | 1.271321e-7 |
GO:0050896 | response to stimulus | 1.829521e-7 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 2.124300e-7 |
GO:0035904 | aorta development | 2.829222e-7 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 3.627276e-7 |
GO:0009201 | ribonucleoside triphosphate biosynthetic process | 4.628654e-7 |
GO:0001974 | blood vessel remodeling | 5.016538e-7 |
GO:2000279 | negative regulation of DNA biosynthetic process | 5.450959e-7 |
GO:0006754 | ATP biosynthetic process | 6.087043e-7 |
GO:0010894 | negative regulation of steroid biosynthetic process | 7.658390e-7 |
GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport | 9.069400e-7 |
GO:0034103 | regulation of tissue remodeling | 9.486580e-7 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 9.869916e-7 |
GO:0006631 | fatty acid metabolic process | 9.952494e-7 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 1.004090e-6 |
GO:0045780 | positive regulation of bone resorption | 1.034957e-6 |
GO:0032787 | monocarboxylic acid metabolic process | 1.169238e-6 |
GO:0034105 | positive regulation of tissue remodeling | 1.325603e-6 |
GO:0006029 | proteoglycan metabolic process | 1.414265e-6 |
GO:0009887 | organ morphogenesis | 1.456268e-6 |
GO:0018149 | peptide cross-linking | 1.618931e-6 |
GO:0051234 | establishment of localization | 1.894803e-6 |
GO:0006633 | fatty acid biosynthetic process | 1.999727e-6 |
GO:0022600 | digestive system process | 2.266861e-6 |
GO:0006810 | transport | 3.113588e-6 |
GO:0048513 | organ development | 3.447169e-6 |
GO:0048856 | anatomical structure development | 3.554757e-6 |
GO:0019408 | dolichol biosynthetic process | 3.862695e-6 |
GO:0008152 | metabolic process | 4.267742e-6 |
GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway | 4.739735e-6 |
GO:0003008 | system process | 4.926648e-6 |
GO:0006706 | steroid catabolic process | 5.145582e-6 |
GO:0015860 | purine nucleoside transport | 5.413637e-6 |
GO:0045124 | regulation of bone resorption | 6.589648e-6 |
GO:0060986 | endocrine hormone secretion | 6.801982e-6 |
GO:0044255 | cellular lipid metabolic process | 8.145596e-6 |
GO:0002328 | pro-B cell differentiation | 8.241680e-6 |
GO:0042221 | response to chemical stimulus | 8.797218e-6 |
GO:2000761 | positive regulation of N-terminal peptidyl-lysine acetylation | 9.405158e-6 |
GO:0035910 | ascending aorta morphogenesis | 9.405158e-6 |
GO:0072530 | purine-containing compound transmembrane transport | 9.755206e-6 |
GO:0045751 | negative regulation of Toll signaling pathway | 9.909561e-6 |
GO:0090288 | negative regulation of cellular response to growth factor stimulus | 1.262215e-5 |
GO:0040019 | positive regulation of embryonic development | 1.442549e-5 |
GO:0032274 | gonadotropin secretion | 1.446212e-5 |
GO:0009152 | purine ribonucleotide biosynthetic process | 1.463609e-5 |
GO:0045746 | negative regulation of Notch signaling pathway | 1.822435e-5 |
GO:0019348 | dolichol metabolic process | 1.918009e-5 |
GO:0015669 | gas transport | 1.948680e-5 |
GO:0046850 | regulation of bone remodeling | 2.003946e-5 |
GO:0009653 | anatomical structure morphogenesis | 2.020615e-5 |
GO:0070563 | negative regulation of vitamin D receptor signaling pathway | 2.145121e-5 |
GO:2000647 | negative regulation of stem cell proliferation | 2.145121e-5 |
GO:0042851 | L-alanine metabolic process | 2.145121e-5 |
GO:0035921 | desmosome disassembly | 2.145121e-5 |
GO:0010839 | negative regulation of keratinocyte proliferation | 2.145121e-5 |
GO:0042180 | cellular ketone metabolic process | 2.404872e-5 |
GO:0006082 | organic acid metabolic process | 2.613981e-5 |
GO:0019752 | carboxylic acid metabolic process | 2.723696e-5 |
GO:0005976 | polysaccharide metabolic process | 2.943916e-5 |
GO:0046314 | phosphocreatine biosynthetic process | 3.174969e-5 |
GO:2000758 | positive regulation of peptidyl-lysine acetylation | 3.339962e-5 |
GO:0045670 | regulation of osteoclast differentiation | 4.250582e-5 |
GO:0048641 | regulation of skeletal muscle tissue development | 4.661769e-5 |
GO:0045672 | positive regulation of osteoclast differentiation | 5.387608e-5 |
GO:2000278 | regulation of DNA biosynthetic process | 5.578184e-5 |
GO:0045081 | negative regulation of interleukin-10 biosynthetic process | 5.786398e-5 |
GO:0046514 | ceramide catabolic process | 5.804136e-5 |
GO:0021522 | spinal cord motor neuron differentiation | 5.845564e-5 |
GO:0048742 | regulation of skeletal muscle fiber development | 5.924505e-5 |
GO:0048731 | system development | 6.362497e-5 |
GO:0042759 | long-chain fatty acid biosynthetic process | 6.415637e-5 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 6.570298e-5 |
GO:0042752 | regulation of circadian rhythm | 6.850607e-5 |
GO:0035108 | limb morphogenesis | 7.113755e-5 |
GO:0044030 | regulation of DNA methylation | 7.149463e-5 |
GO:0045128 | negative regulation of reciprocal meiotic recombination | 7.197055e-5 |
GO:0006311 | meiotic gene conversion | 7.197055e-5 |
GO:0006467 | protein thiol-disulfide exchange | 7.406349e-5 |
GO:0003209 | cardiac atrium morphogenesis | 8.002573e-5 |
GO:0006198 | cAMP catabolic process | 8.175749e-5 |
GO:0060556 | regulation of vitamin D biosynthetic process | 8.975403e-5 |
GO:0043048 | dolichyl monophosphate biosynthetic process | 9.533180e-5 |
GO:0070562 | regulation of vitamin D receptor signaling pathway | 9.601479e-5 |
GO:0016525 | negative regulation of angiogenesis | 9.656429e-5 |
GO:0051561 | elevation of mitochondrial calcium ion concentration | 9.811207e-5 |
GO:0007275 | multicellular organismal development | 9.886445e-5 |
GO:0048771 | tissue remodeling | 9.930685e-5 |
GO:0048729 | tissue morphogenesis | 9.956435e-5 |
GO:0060173 | limb development | 1.007029e-4 |
GO:0006629 | lipid metabolic process | 1.017470e-4 |
GO:0009260 | ribonucleotide biosynthetic process | 1.047916e-4 |
GO:0045835 | negative regulation of meiosis | 1.065922e-4 |
GO:0009888 | tissue development | 1.168034e-4 |
GO:0002344 | B cell affinity maturation | 1.181853e-4 |
GO:0032502 | developmental process | 1.240651e-4 |
GO:0035964 | COPI-coated vesicle budding | 1.262080e-4 |
GO:0060972 | left/right pattern formation | 1.415391e-4 |
GO:0002339 | B cell selection | 1.415391e-4 |
GO:0046826 | negative regulation of protein export from nucleus | 1.489618e-4 |
GO:0044238 | primary metabolic process | 1.579090e-4 |
GO:0032846 | positive regulation of homeostatic process | 1.652960e-4 |
GO:0009308 | amine metabolic process | 1.676953e-4 |
GO:0021515 | cell differentiation in spinal cord | 1.678769e-4 |
GO:0050906 | detection of stimulus involved in sensory perception | 1.726473e-4 |
GO:0008593 | regulation of Notch signaling pathway | 1.746061e-4 |
GO:0007155 | cell adhesion | 1.813545e-4 |
GO:0045814 | negative regulation of gene expression, epigenetic | 1.944798e-4 |
GO:0022610 | biological adhesion | 1.987933e-4 |
GO:0051640 | organelle localization | 2.027280e-4 |
GO:0031953 | negative regulation of protein autophosphorylation | 2.111728e-4 |
GO:0051093 | negative regulation of developmental process | 2.155390e-4 |
GO:0010288 | response to lead ion | 2.164167e-4 |
GO:0046394 | carboxylic acid biosynthetic process | 2.233750e-4 |
GO:0070585 | protein localization in mitochondrion | 2.285545e-4 |
GO:0045595 | regulation of cell differentiation | 2.672655e-4 |
GO:0015858 | nucleoside transport | 2.725411e-4 |
GO:0032805 | positive regulation of low-density lipoprotein particle receptor catabolic process | 2.811375e-4 |
GO:0060806 | negative regulation of cell differentiation involved in embryonic placenta development | 2.811375e-4 |
GO:2000756 | regulation of peptidyl-lysine acetylation | 3.067674e-4 |
GO:0007608 | sensory perception of smell | 3.072045e-4 |
GO:0003289 | atrial septum primum morphogenesis | 3.110119e-4 |
GO:0072001 | renal system development | 3.196261e-4 |
GO:0003230 | cardiac atrium development | 3.238859e-4 |
GO:0051659 | maintenance of mitochondrion location | 3.333915e-4 |
GO:0007519 | skeletal muscle tissue development | 3.374743e-4 |
GO:0001655 | urogenital system development | 3.416232e-4 |
GO:0048704 | embryonic skeletal system morphogenesis | 3.554586e-4 |
GO:0070869 | heterochromatin formation involved in chromatin silencing | 3.590334e-4 |
GO:0072274 | metanephric glomerular basement membrane development | 3.682670e-4 |
GO:0072249 | metanephric glomerular visceral epithelial cell development | 3.682670e-4 |
GO:0048677 | axon extension involved in regeneration | 3.682670e-4 |
GO:0051646 | mitochondrion localization | 3.737823e-4 |
GO:0021510 | spinal cord development | 3.764555e-4 |
GO:0034374 | low-density lipoprotein particle remodeling | 3.846459e-4 |
GO:0044242 | cellular lipid catabolic process | 4.050385e-4 |
GO:0007165 | signal transduction | 4.055100e-4 |
GO:0030330 | DNA damage response, signal transduction by p53 class mediator | 4.112304e-4 |
GO:0010641 | positive regulation of platelet-derived growth factor receptor signaling pathway | 4.127881e-4 |
GO:0048644 | muscle organ morphogenesis | 4.309469e-4 |
GO:0010817 | regulation of hormone levels | 4.463810e-4 |
GO:0001501 | skeletal system development | 4.569191e-4 |
GO:0016576 | histone dephosphorylation | 4.663460e-4 |
GO:0048343 | paraxial mesodermal cell fate commitment | 4.670187e-4 |
GO:0014049 | positive regulation of glutamate secretion | 4.696465e-4 |
GO:0032728 | positive regulation of interferon-beta production | 4.779499e-4 |
GO:0060538 | skeletal muscle organ development | 4.798575e-4 |
GO:0051155 | positive regulation of striated muscle cell differentiation | 4.894357e-4 |
GO:0051657 | maintenance of organelle location | 4.944602e-4 |
GO:0044283 | small molecule biosynthetic process | 5.269441e-4 |
GO:0051149 | positive regulation of muscle cell differentiation | 5.280000e-4 |
GO:0016042 | lipid catabolic process | 5.320631e-4 |
GO:0044281 | small molecule metabolic process | 5.402147e-4 |
GO:0007589 | body fluid secretion | 5.452889e-4 |
GO:0060631 | regulation of meiosis I | 5.531604e-4 |
GO:0010033 | response to organic substance | 5.584922e-4 |
GO:0060563 | neuroepithelial cell differentiation | 5.587896e-4 |
GO:0050886 | endocrine process | 5.814647e-4 |
GO:0009395 | phospholipid catabolic process | 5.816108e-4 |
GO:0009914 | hormone transport | 6.151462e-4 |
GO:0048311 | mitochondrion distribution | 6.202203e-4 |
GO:0001822 | kidney development | 6.246987e-4 |
GO:0007606 | sensory perception of chemical stimulus | 6.349849e-4 |
GO:0046879 | hormone secretion | 6.452172e-4 |
GO:0060537 | muscle tissue development | 6.725867e-4 |
GO:0046466 | membrane lipid catabolic process | 6.798241e-4 |
GO:0021516 | dorsal spinal cord development | 6.798241e-4 |
GO:0007229 | integrin-mediated signaling pathway | 6.938463e-4 |
GO:0044237 | cellular metabolic process | 6.980904e-4 |
GO:0032321 | positive regulation of Rho GTPase activity | 7.091326e-4 |
GO:0046689 | response to mercury ion | 7.149310e-4 |
GO:0002064 | epithelial cell development | 7.187418e-4 |
GO:0006643 | membrane lipid metabolic process | 7.217259e-4 |
GO:0009214 | cyclic nucleotide catabolic process | 7.222931e-4 |
GO:0010042 | response to manganese ion | 7.302208e-4 |
GO:0048199 | vesicle targeting, to, from or within Golgi | 7.659187e-4 |
GO:0035786 | protein complex oligomerization | 7.745937e-4 |
GO:0002009 | morphogenesis of an epithelium | 8.196456e-4 |
GO:0001736 | establishment of planar polarity | 8.818097e-4 |
GO:0044241 | lipid digestion | 8.860336e-4 |
GO:0042249 | establishment of planar polarity of embryonic epithelium | 8.995623e-4 |
GO:0010232 | vascular transport | 9.468155e-4 |
GO:0021782 | glial cell development | 1.006830e-3 |
GO:0045187 | regulation of circadian sleep/wake cycle, sleep | 1.027409e-3 |
GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration | 1.032289e-3 |
GO:0080134 | regulation of response to stress | 1.042806e-3 |
GO:0048512 | circadian behavior | 1.056145e-3 |
GO:0050711 | negative regulation of interleukin-1 secretion | 1.060819e-3 |
GO:0035295 | tube development | 1.069613e-3 |
GO:0042769 | DNA damage response, detection of DNA damage | 1.073724e-3 |
GO:0010043 | response to zinc ion | 1.101244e-3 |
GO:0001516 | prostaglandin biosynthetic process | 1.108459e-3 |
GO:0051239 | regulation of multicellular organismal process | 1.144025e-3 |
GO:0006665 | sphingolipid metabolic process | 1.150608e-3 |
GO:0003357 | noradrenergic neuron differentiation | 1.159892e-3 |
GO:0032692 | negative regulation of interleukin-1 production | 1.187431e-3 |
GO:0051179 | localization | 1.193466e-3 |
GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing | 1.203548e-3 |
GO:0015867 | ATP transport | 1.203548e-3 |
GO:0015868 | purine ribonucleotide transport | 1.205342e-3 |
GO:0018209 | peptidyl-serine modification | 1.209780e-3 |
GO:0048539 | bone marrow development | 1.271645e-3 |
GO:0060312 | regulation of blood vessel remodeling | 1.271645e-3 |
GO:0010520 | regulation of reciprocal meiotic recombination | 1.271645e-3 |
GO:0060413 | atrial septum morphogenesis | 1.273089e-3 |
GO:0001967 | suckling behavior | 1.273089e-3 |
GO:0060426 | lung vasculature development | 1.302537e-3 |
GO:0023052 | signaling | 1.314747e-3 |
GO:0042060 | wound healing | 1.339624e-3 |
GO:0030149 | sphingolipid catabolic process | 1.349757e-3 |
GO:0016090 | prenol metabolic process | 1.365338e-3 |
GO:0010038 | response to metal ion | 1.366766e-3 |
GO:0000710 | meiotic mismatch repair | 1.387044e-3 |
GO:0061061 | muscle structure development | 1.420273e-3 |
GO:0006603 | phosphocreatine metabolic process | 1.432646e-3 |
GO:0046903 | secretion | 1.466502e-3 |
GO:0040020 | regulation of meiosis | 1.490250e-3 |
GO:0006705 | mineralocorticoid biosynthetic process | 1.497904e-3 |
GO:2000026 | regulation of multicellular organismal development | 1.517374e-3 |
GO:0044243 | multicellular organismal catabolic process | 1.544836e-3 |
GO:0007164 | establishment of tissue polarity | 1.571575e-3 |
GO:0046549 | retinal cone cell development | 1.577874e-3 |
GO:0051147 | regulation of muscle cell differentiation | 1.678552e-3 |
GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator | 1.682986e-3 |
GO:0003183 | mitral valve morphogenesis | 1.682986e-3 |
GO:0045989 | positive regulation of striated muscle contraction | 1.707647e-3 |
GO:0010519 | negative regulation of phospholipase activity | 1.730715e-3 |
GO:0060287 | epithelial cilium movement involved in determination of left/right asymmetry | 1.737129e-3 |
GO:0046034 | ATP metabolic process | 1.775305e-3 |
GO:0001710 | mesodermal cell fate commitment | 1.780136e-3 |
GO:0001676 | long-chain fatty acid metabolic process | 1.795406e-3 |
GO:0022010 | central nervous system myelination | 1.808275e-3 |
GO:0032808 | lacrimal gland development | 1.860595e-3 |
GO:0060415 | muscle tissue morphogenesis | 1.898238e-3 |
GO:0000132 | establishment of mitotic spindle orientation | 1.926703e-3 |
GO:0045596 | negative regulation of cell differentiation | 1.927064e-3 |
GO:0002763 | positive regulation of myeloid leukocyte differentiation | 1.942882e-3 |
GO:0032025 | response to cobalt ion | 1.950171e-3 |
GO:0045637 | regulation of myeloid cell differentiation | 2.033056e-3 |
GO:0060338 | regulation of type I interferon-mediated signaling pathway | 2.043356e-3 |
GO:0051096 | positive regulation of helicase activity | 2.043533e-3 |
GO:0015893 | drug transport | 2.082243e-3 |
GO:0010350 | cellular response to magnesium starvation | 2.088251e-3 |
GO:0001503 | ossification | 2.112694e-3 |
GO:0006626 | protein targeting to mitochondrion | 2.134841e-3 |
GO:0031016 | pancreas development | 2.150351e-3 |
GO:0030263 | apoptotic chromosome condensation | 2.186688e-3 |
GO:0001913 | T cell mediated cytotoxicity | 2.186688e-3 |
GO:0072560 | type B pancreatic cell maturation | 2.231738e-3 |
GO:0009987 | cellular process | 2.243497e-3 |
GO:0051173 | positive regulation of nitrogen compound metabolic process | 2.289334e-3 |
GO:0042632 | cholesterol homeostasis | 2.329870e-3 |
GO:0042745 | circadian sleep/wake cycle | 2.330499e-3 |
GO:0006693 | prostaglandin metabolic process | 2.330499e-3 |
GO:0046541 | saliva secretion | 2.382417e-3 |
GO:0002761 | regulation of myeloid leukocyte differentiation | 2.409078e-3 |
GO:0007166 | cell surface receptor linked signaling pathway | 2.436736e-3 |
GO:0043570 | maintenance of DNA repeat elements | 2.440235e-3 |
GO:0072655 | establishment of protein localization in mitochondrion | 2.443531e-3 |
GO:0048333 | mesodermal cell differentiation | 2.464477e-3 |
GO:0007154 | cell communication | 2.468136e-3 |
GO:0060021 | palate development | 2.523864e-3 |
GO:0051445 | regulation of meiotic cell cycle | 2.539154e-3 |
GO:0031529 | ruffle organization | 2.573077e-3 |
GO:0030900 | forebrain development | 2.603899e-3 |
GO:0043009 | chordate embryonic development | 2.614174e-3 |
GO:0051224 | negative regulation of protein transport | 2.626780e-3 |
GO:0009790 | embryo development | 2.650069e-3 |
GO:0040001 | establishment of mitotic spindle localization | 2.666597e-3 |
GO:0060429 | epithelium development | 2.705804e-3 |
GO:0006851 | mitochondrial calcium ion transport | 2.724234e-3 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 2.734102e-3 |
GO:0050793 | regulation of developmental process | 2.771234e-3 |
GO:0071383 | cellular response to steroid hormone stimulus | 2.789924e-3 |
GO:0010720 | positive regulation of cell development | 2.884110e-3 |
GO:0015939 | pantothenate metabolic process | 2.903923e-3 |
GO:0009125 | nucleoside monophosphate catabolic process | 2.913926e-3 |
GO:0042396 | phosphagen biosynthetic process | 2.947915e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 2.949028e-3 |
GO:0051153 | regulation of striated muscle cell differentiation | 2.952617e-3 |
GO:0042938 | dipeptide transport | 3.011978e-3 |
GO:0007622 | rhythmic behavior | 3.069576e-3 |
GO:2001021 | negative regulation of response to DNA damage stimulus | 3.074464e-3 |
GO:0072331 | signal transduction by p53 class mediator | 3.115773e-3 |
GO:0032648 | regulation of interferon-beta production | 3.118279e-3 |
GO:0045639 | positive regulation of myeloid cell differentiation | 3.120352e-3 |
GO:0031571 | mitotic cell cycle G1/S transition DNA damage checkpoint | 3.180424e-3 |
GO:0050974 | detection of mechanical stimulus involved in sensory perception | 3.204871e-3 |
GO:0014706 | striated muscle tissue development | 3.234480e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 3.259367e-3 |
GO:0051606 | detection of stimulus | 3.317693e-3 |
GO:0060632 | regulation of microtubule-based movement | 3.353123e-3 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 3.353123e-3 |
GO:0042770 | signal transduction in response to DNA damage | 3.362689e-3 |
GO:0016925 | protein sumoylation | 3.398851e-3 |
GO:0051094 | positive regulation of developmental process | 3.404077e-3 |
GO:0048935 | peripheral nervous system neuron development | 3.414662e-3 |
GO:0014045 | establishment of endothelial blood-brain barrier | 3.486921e-3 |
GO:0061028 | establishment of endothelial barrier | 3.545744e-3 |
GO:0031018 | endocrine pancreas development | 3.561780e-3 |
GO:0051095 | regulation of helicase activity | 3.583744e-3 |
GO:0009611 | response to wounding | 3.586714e-3 |
GO:0046825 | regulation of protein export from nucleus | 3.594992e-3 |
GO:0070206 | protein trimerization | 3.613790e-3 |
GO:0021517 | ventral spinal cord development | 3.662948e-3 |
GO:0007156 | homophilic cell adhesion | 3.782530e-3 |
GO:0014834 | satellite cell maintenance involved in skeletal muscle regeneration | 3.782746e-3 |
GO:0022410 | circadian sleep/wake cycle process | 3.845702e-3 |
GO:0014009 | glial cell proliferation | 3.850710e-3 |
GO:0072422 | signal transduction involved in DNA damage checkpoint | 4.020032e-3 |
GO:0021796 | cerebral cortex regionalization | 4.047544e-3 |
GO:0042891 | antibiotic transport | 4.075590e-3 |
GO:0032231 | regulation of actin filament bundle assembly | 4.084111e-3 |
GO:0045932 | negative regulation of muscle contraction | 4.376765e-3 |
GO:0051036 | regulation of endosome size | 4.488663e-3 |
GO:0035582 | negative regulation of BMP signaling pathway by extracellular sequestering of BMP | 4.488663e-3 |
GO:0019428 | allantoin biosynthetic process | 4.488663e-3 |
GO:0006790 | sulfur compound metabolic process | 4.553799e-3 |
GO:0045597 | positive regulation of cell differentiation | 4.619381e-3 |
GO:0048665 | neuron fate specification | 4.771642e-3 |
GO:0045935 | positive regulation of nucleobase-containing compound metabolic process | 4.791721e-3 |
GO:0009792 | embryo development ending in birth or egg hatching | 4.896956e-3 |
GO:0051053 | negative regulation of DNA metabolic process | 4.929717e-3 |
GO:0006164 | purine nucleotide biosynthetic process | 4.939361e-3 |
GO:0001937 | negative regulation of endothelial cell proliferation | 4.998687e-3 |
GO:0007417 | central nervous system development | 5.009419e-3 |
GO:0048514 | blood vessel morphogenesis | 5.149140e-3 |
GO:0023061 | signal release | 5.185213e-3 |
GO:0090317 | negative regulation of intracellular protein transport | 5.234476e-3 |
GO:0090076 | relaxation of skeletal muscle | 5.235382e-3 |
GO:0032470 | elevation of endoplasmic reticulum calcium ion concentration | 5.235382e-3 |
GO:0043313 | regulation of neutrophil degranulation | 5.235382e-3 |
GO:0006301 | postreplication repair | 5.356838e-3 |
GO:0051293 | establishment of spindle localization | 5.374701e-3 |
GO:0070541 | response to platinum ion | 5.399536e-3 |
GO:0045039 | protein import into mitochondrial inner membrane | 5.424019e-3 |
GO:0010001 | glial cell differentiation | 5.448531e-3 |
GO:0002827 | positive regulation of T-helper 1 type immune response | 5.448650e-3 |
GO:0009628 | response to abiotic stimulus | 5.500346e-3 |
GO:0009267 | cellular response to starvation | 5.513013e-3 |
GO:0042448 | progesterone metabolic process | 5.650390e-3 |
GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II | 5.650390e-3 |
GO:0009100 | glycoprotein metabolic process | 5.673216e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 5.704240e-3 |
GO:0046381 | CMP-N-acetylneuraminate metabolic process | 5.803598e-3 |
GO:0060577 | pulmonary vein morphogenesis | 5.847581e-3 |
GO:0006030 | chitin metabolic process | 5.878281e-3 |
GO:0001561 | fatty acid alpha-oxidation | 5.878281e-3 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 5.890897e-3 |
GO:0032481 | positive regulation of type I interferon production | 5.908485e-3 |
GO:0007076 | mitotic chromosome condensation | 6.038212e-3 |
GO:0002577 | regulation of antigen processing and presentation | 6.068044e-3 |
GO:0032319 | regulation of Rho GTPase activity | 6.126577e-3 |
GO:0032094 | response to food | 6.258173e-3 |
GO:0046415 | urate metabolic process | 6.302262e-3 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 6.302262e-3 |
GO:0046456 | icosanoid biosynthetic process | 6.323107e-3 |
GO:0045214 | sarcomere organization | 6.330377e-3 |
GO:0018101 | peptidyl-citrulline biosynthetic process from peptidyl-arginine | 6.418064e-3 |
GO:0001542 | ovulation from ovarian follicle | 6.435247e-3 |
GO:0031573 | intra-S DNA damage checkpoint | 6.592650e-3 |
GO:0005975 | carbohydrate metabolic process | 6.700819e-3 |
GO:0050911 | detection of chemical stimulus involved in sensory perception of smell | 6.745700e-3 |
GO:0048518 | positive regulation of biological process | 6.759314e-3 |
GO:0045671 | negative regulation of osteoclast differentiation | 6.831060e-3 |
GO:0045074 | regulation of interleukin-10 biosynthetic process | 6.889874e-3 |
GO:0048386 | positive regulation of retinoic acid receptor signaling pathway | 6.910537e-3 |
GO:0060174 | limb bud formation | 6.922655e-3 |
GO:0035023 | regulation of Rho protein signal transduction | 6.956953e-3 |
GO:0006839 | mitochondrial transport | 6.963175e-3 |
GO:0034113 | heterotypic cell-cell adhesion | 6.994973e-3 |
GO:0003323 | type B pancreatic cell development | 7.079324e-3 |
GO:0014034 | neural crest cell fate commitment | 7.114542e-3 |
GO:0050982 | detection of mechanical stimulus | 7.189862e-3 |
GO:0034605 | cellular response to heat | 7.228152e-3 |
GO:0001837 | epithelial to mesenchymal transition | 7.312670e-3 |
GO:0034097 | response to cytokine stimulus | 7.356069e-3 |
GO:0010447 | response to acidity | 7.369539e-3 |
GO:0035239 | tube morphogenesis | 7.541286e-3 |
GO:0007512 | adult heart development | 7.552775e-3 |
GO:0001708 | cell fate specification | 7.576100e-3 |
GO:0031328 | positive regulation of cellular biosynthetic process | 7.611683e-3 |
GO:0003170 | heart valve development | 7.788008e-3 |
GO:0006357 | regulation of transcription from RNA polymerase II promoter | 7.811897e-3 |
GO:0003007 | heart morphogenesis | 7.867625e-3 |
GO:0030177 | positive regulation of Wnt receptor signaling pathway | 7.890945e-3 |
GO:0055114 | oxidation-reduction process | 7.947333e-3 |
GO:0048710 | regulation of astrocyte differentiation | 7.953871e-3 |
GO:0090141 | positive regulation of mitochondrial fission | 7.956857e-3 |
GO:0000114 | regulation of transcription involved in G1 phase of mitotic cell cycle | 7.956857e-3 |
GO:0060578 | superior vena cava morphogenesis | 7.956857e-3 |
GO:0001738 | morphogenesis of a polarized epithelium | 8.088642e-3 |
GO:0010628 | positive regulation of gene expression | 8.185511e-3 |
GO:0016446 | somatic hypermutation of immunoglobulin genes | 8.436103e-3 |
GO:0071333 | cellular response to glucose stimulus | 8.580163e-3 |
GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound | 8.580857e-3 |
GO:0060284 | regulation of cell development | 8.730891e-3 |
GO:0006457 | protein folding | 8.772848e-3 |
GO:0060525 | prostate glandular acinus development | 8.978426e-3 |
GO:0014063 | negative regulation of serotonin secretion | 8.979387e-3 |
GO:0048642 | negative regulation of skeletal muscle tissue development | 8.985874e-3 |
GO:0045988 | negative regulation of striated muscle contraction | 9.122935e-3 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 9.123339e-3 |
GO:0045722 | positive regulation of gluconeogenesis | 9.123339e-3 |
GO:0003341 | cilium movement | 9.155997e-3 |
GO:0030299 | intestinal cholesterol absorption | 9.159136e-3 |
GO:0003283 | atrial septum development | 9.218643e-3 |
GO:0006636 | unsaturated fatty acid biosynthetic process | 9.325205e-3 |
GO:0010524 | positive regulation of calcium ion transport into cytosol | 9.353000e-3 |
GO:0090140 | regulation of mitochondrial fission | 9.719090e-3 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 9.719090e-3 |
GO:0007399 | nervous system development | 9.732018e-3 |
GO:0051051 | negative regulation of transport | 9.754443e-3 |
GO:0035270 | endocrine system development | 9.756721e-3 |
GO:0051656 | establishment of organelle localization | 9.851457e-3 |
GO:0001946 | lymphangiogenesis | 9.928029e-3 |
GO:0048598 | embryonic morphogenesis | 1.013542e-2 |
GO:0030001 | metal ion transport | 1.015561e-2 |
GO:0008207 | C21-steroid hormone metabolic process | 1.024564e-2 |
GO:0031448 | positive regulation of fast-twitch skeletal muscle fiber contraction | 1.025101e-2 |
GO:0007501 | mesodermal cell fate specification | 1.025101e-2 |
GO:0060296 | regulation of cilium beat frequency involved in ciliary motility | 1.031961e-2 |
GO:0010815 | bradykinin catabolic process | 1.031961e-2 |
GO:0001678 | cellular glucose homeostasis | 1.035789e-2 |
GO:0030031 | cell projection assembly | 1.039724e-2 |
GO:0060562 | epithelial tube morphogenesis | 1.050755e-2 |
GO:0032107 | regulation of response to nutrient levels | 1.073665e-2 |
GO:0001778 | plasma membrane repair | 1.074451e-2 |
GO:0046069 | cGMP catabolic process | 1.074451e-2 |
GO:0055085 | transmembrane transport | 1.081706e-2 |
GO:0060285 | ciliary cell motility | 1.089507e-2 |
GO:0010963 | regulation of L-arginine import | 1.089507e-2 |
GO:0008610 | lipid biosynthetic process | 1.090150e-2 |
GO:0051716 | cellular response to stimulus | 1.093183e-2 |
GO:0009056 | catabolic process | 1.106262e-2 |
GO:0030252 | growth hormone secretion | 1.116445e-2 |
GO:0016337 | cell-cell adhesion | 1.126979e-2 |
GO:0051602 | response to electrical stimulus | 1.149942e-2 |
GO:0032479 | regulation of type I interferon production | 1.161978e-2 |
GO:0032026 | response to magnesium ion | 1.174879e-2 |
GO:0043403 | skeletal muscle tissue regeneration | 1.177010e-2 |
GO:0034474 | U2 snRNA 3'-end processing | 1.177378e-2 |
GO:0090241 | negative regulation of histone H4 acetylation | 1.177378e-2 |
GO:0034401 | regulation of transcription by chromatin organization | 1.177378e-2 |
GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation | 1.193093e-2 |
GO:0043420 | anthranilate metabolic process | 1.193093e-2 |
GO:0034516 | response to vitamin B6 | 1.193093e-2 |
GO:0030522 | intracellular receptor mediated signaling pathway | 1.202900e-2 |
GO:0035264 | multicellular organism growth | 1.206926e-2 |
GO:0051567 | histone H3-K9 methylation | 1.218307e-2 |
GO:0001547 | antral ovarian follicle growth | 1.218307e-2 |
GO:0010738 | regulation of protein kinase A signaling cascade | 1.221342e-2 |
GO:0046847 | filopodium assembly | 1.238885e-2 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 1.251136e-2 |
GO:0006787 | porphyrin-containing compound catabolic process | 1.251136e-2 |
GO:0006690 | icosanoid metabolic process | 1.276301e-2 |
GO:0032108 | negative regulation of response to nutrient levels | 1.284225e-2 |
GO:0046823 | negative regulation of nucleocytoplasmic transport | 1.286406e-2 |
GO:0032856 | activation of Ras GTPase activity | 1.289138e-2 |
GO:0030728 | ovulation | 1.318511e-2 |
GO:0022009 | central nervous system vasculogenesis | 1.324348e-2 |
GO:0032488 | Cdc42 protein signal transduction | 1.349668e-2 |
GO:0003347 | epicardial cell to mesenchymal cell transition | 1.351717e-2 |
GO:0045765 | regulation of angiogenesis | 1.357652e-2 |
GO:0045995 | regulation of embryonic development | 1.389523e-2 |
GO:0051089 | constitutive protein ectodomain proteolysis | 1.395842e-2 |
GO:0070836 | caveola assembly | 1.395842e-2 |
GO:0035583 | negative regulation of transforming growth factor beta receptor signaling pathway by extracellular sequestering of TGFbeta | 1.395842e-2 |
GO:0019240 | citrulline biosynthetic process | 1.395842e-2 |
GO:0048583 | regulation of response to stimulus | 1.399750e-2 |
GO:0050907 | detection of chemical stimulus involved in sensory perception | 1.429607e-2 |
GO:0051705 | behavioral interaction between organisms | 1.442662e-2 |
GO:0072513 | positive regulation of secondary heart field cardioblast proliferation | 1.443401e-2 |
GO:0003272 | endocardial cushion formation | 1.452069e-2 |
GO:0043501 | skeletal muscle adaptation | 1.453701e-2 |